Aural Analytics develops a cloud-based, model-driven speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into extensible APIs and clinical-grade mobile and web products. The platform is mobile-first, disease-, language- and device-agnostic, and has been deployed in eight languages across four continents. The company’s technology is grounded in more than 25 years of NIH- and NSF-funded speech neuroscience research and has been clinically validated in multiple disease indications. Aural’s tools are used in interventional clinical trials, observational research, and clinical and consumer settings to detect speech changes associated with neurological conditions. Planned uses of new funding include expansion of the clinical trial platform, a global release of a next-generation integration portal for easier speech collection and analytics, new clinical-grade mobile and web products, and researcher tool kits to accelerate speech neuroscience breakthroughs. The company was founded in 2015 and maintains headquarters in Scottsdale, Ariz.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Sep 2019